Is This Popular Quantum Computing Stock Heading for an 80% Crash?

Rigetti generated $7.1M in revenue in 2025, a 34% decline from $10.8M in 2024, with a GAAP net loss of $216.2M and an adjusted non-GAAP loss of $50.5M while ending the year with $589.8M in cash. The stock is down ~72% from its peak yet trades at an outsized P/S of 703 (vs. Nvidia 19.9 and Palantir 92.1), implying another ~80–87% downside would be required to reach peers' valuations. Technically the company has strong gate-fidelity results (Cepheus-1-36Q at 99.5%; prototype 99.9%) but commercialization timelines remain distant (Ark projects RSA-2048-capable machines decades out), supporting a risk-off stance on the equity.

Analysis

Rigetti’s vertically integrated model creates a high fixed-cost structure that magnifies downside when commercial traction lags; that same structure is an asset in an M&A or strategic-partnership scenario because it consolidates tooling, IP, and a foundry path few rivals can match. The logical beneficiaries of slower-than-expected quantum commercialization are incumbents selling classical compute and orchestration (hardware accelerators, cloud stacks, and software) since budgets will continue to flow into incremental classical performance and hybrid workflows.

Key catalysts to watch are operational (replicable fidelity at scale, multi-customer commercial trials) and corporate (strategic partnerships or tuck-in acquisition by a hyperscaler or chip vendor). Near-term market-moving events are quarterly guidance and cash-management signals over the next 6-12 months; medium-term binary outcomes (demo replication, large enterprise contract, or a strategic bid) will determine whether the story stays speculative or converts to meaningful valuation support.

The consensus has priced in a rapid commercialization path; that positioning makes short exposure asymmetrically attractive while leaving a low-cost asymmetric long for binary upside. Second-order plays include vendors in the semiconductor supply chain and cloud operators whose product roadmaps and service monetization benefit if quantum adoption is delayed—those names are positioned to collect the reallocated R&D and enterprise spend.

Tail risks that would reverse the trend are narrow but potent: a reproducible, peer-reviewed fidelity breakthrough, a hyperscaler partner deal that guarantees multi-year cloud revenue, or national-security driven procurement programs that bypass normal commercial adoption cycles. Each of those would compress implied downside quickly, so trade sizing and option hedges matter more than conviction in direction alone.

Key Decisions for Investors

• Short RGTI equity (size 1–2% net exposure) with a 6–12 month horizon; target asymmetric return of 2–4x if commercial metrics disappoint or dilution occurs; hard stop at 25–35% adverse move to limit gap/volatility risk.
• Pair trade: short RGTI / long NVDA or GOOGL (1:1 notional) for 3–12 months to express relative-technology resilience; this captures reallocation from speculative quantum to AI/cloud incumbents—expect positive carry from margin re-rating if quantum timelines slip; monitor catalyst: enterprise cloud deal announcements and NVDA data-center guidance.
• Buy low-cost asymmetric upside: long-dated (12–24 month) OTM RGTI calls sized 0.5–1% of portfolio as a lottery ticket for a reproducible technical breakthrough or strategic acquisition; maximum loss = premium paid, payoff potential >> premium if binary event occurs.
• Structured hedge: purchase a 9–12 month RGTI put spread to monetize near-term downside while capping cost (pay small premium for limited-risk payoff); use if you are short underlying to reduce margin consumption and control tail exposure.